Literature DB >> 15076940

Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy.

Kaori Takaya1, Yukihiko Suzuki, Hideyuki Mizutani, Tomoki Sakuraba, Mitsuru Nakazawa.   

Abstract

PURPOSE: To investigate long-term results of vitrectomy for the removal of submacular hard exudates in patients with diabetic maculopathy.
METHODS: Thirteen eyes of 10 patients with diabetic maculopathy underwent vitrectomy to remove submacular hard exudates from December 1993 to March 1999. The mean preoperative logMAR visual acuity +/- SD was 1.54 +/- 0.43. Preoperatively, the exudates ranged from 0.5 to 3 disk diameters (average, 1.25 disk diameters). Exudates were removed using subretinal forceps through a minimal paramacular retinotomy after vitrectomy. In all cases, 20% SF6 gas tamponade was added. The mean postoperative observation period was 43.2 months.
RESULTS: Visual acuity was improved in 7 eyes (54%) 1 year after surgery; however, visual acuity over longer periods was improved in only 5 eyes (38%) as compared with the preoperative findings. The mean final visual acuity +/- SD was 1.62 +/- 0.59, which did not show statistically significant improvement over that in the control group. Although submacular hard exudates and macular edema disappeared during the postoperative period, atrophic or degenerative changes occurred in many cases.
CONCLUSION: Visual improvement could not be obtained for a long period after removing submacular hard exudates in most of the patients, suggesting that diabetic maculopathy should be treated before massive exudate deposits appear in the macula.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076940     DOI: 10.1097/00006982-200402000-00004

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Choroidal neovascularisation after surgical removal of submacular lipid plaques in diabetic maculopathy.

Authors:  Daniela Suesskind; Faik Gelisken; Karl U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-19       Impact factor: 3.117

2.  Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

Authors:  Remzi Avci; Berkant Kaderli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

Review 3.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

4.  Removal of Subfoveal Massive Hard Exudates through an Intentional Macular Hole in Patients with Diabetic Maculopathy: A Report of Three Cases.

Authors:  Yukako Iwane; Hisanori Imai; Hiroko Yamada; Yasuyuki Sotani; Mariko Oishi; Makoto Nakamura
Journal:  Case Rep Ophthalmol       Date:  2022-08-29

Review 5.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

6.  Vitrectomy with internal limiting membrane peeling versus nonsurgical treatment for diabetic macular edema with massive hard exudates.

Authors:  Hsuan-Chieh Lin; Chung-May Yang; San-Ni Chen; Yi-Ting Hsieh
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

Review 7.  Diabetic macular edema: Evidence-based management.

Authors:  David J Browning; Michael W Stewart; Chong Lee
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.